![[Logo]FUJIFILM](/en/template/images/gHeader_brandLogo_02.gif){kind=small}
![[Logo]KYOWA KIRIN](/en/template/images/gHeader_brandLogo_01.gif){kind=small}
![[Logo]FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd.](/en/template/images/gHeader_coName_01.gif){kind=small}
Our Products
| Code name | International Nonproprietary Name | Therapeutic Area (Main Indications) |
Status |
|---|---|---|---|
| FKB327 | Adalimumab （Fully-Human Anti-TNF-α Monoclonal Antibody） |
Immunology (Rheumatoid Arthritis, Psoriasis, Crohn's Disease) |
Launched in EU Countries in 2018（Hulio®） Launched in Japan, Canada, Switzerland in 2021. |
